Tag: InVite study

Advocates for Women with Breast Cancer

In any big fight it helps to have someone in your corner and when it comes to breast cancer you want someone like Elyse Spatz Caplan and the people at Living Beyond Breast Cancer. Elyse, who herself was diagnosed and treated for breast cancer in 1991, oversees educational programming for Living Beyond ...

Read more

Incorporating Technology and DNA Testing into Clinical Trials

Many expensive clinical trials fail because the therapy causes harmful side effects in some or all participants or the drug isn’t effective across the board. Genetics may explain differences in response, but as of today DNA testing isn’t a standard part of clinical trials. Integrating genetic testing into ...

Read more

Participating in Genetic Research

Not all cancers are created equal. Ask anyone with metastatic breast cancer. For the 155,000 women in the United States living with this diagnosis, each day represents a constant fight against a cancer that has spread into other parts of their bodies — most often their bones, liver, lungs or brain. With ...

Read more

Participating in Metastatic Breast Cancer Research

Earlier this year 23andMe and Genentech launched an online study of metastatic breast cancer to learn more about how genes might play a role in how a person responds to bevacizumab, also known as Avastin®. (Avastin® is not approved by the FDA for treatment of metastatic breast cancer.) Since women began to ...

Read more

Breast Size Matters — But Not In The Way You Think

With Nick Eriksson Social norms and preferences aside, it turns out that breast size matters -- but not quite in the way you think. 23andMe’s latest research paper, published in the journal BMC Medical Genetics, shows that genetic factors influence whether women have double As or double Ds. This might ...

Read more

Return to top